cilostazol has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Safety parameters were changes in nerve conduction studies as well as reporting of adverse events." | 6.76 | Cilostazol: a pilot study on safety and clinical efficacy in neuropathies of diabetes mellitus type 2 (ASCEND). ( Mercado-Asis, LB; Rosales, RL; Santos, MM, 2011) |
| " Safety parameters were changes in nerve conduction studies as well as reporting of adverse events." | 2.76 | Cilostazol: a pilot study on safety and clinical efficacy in neuropathies of diabetes mellitus type 2 (ASCEND). ( Mercado-Asis, LB; Rosales, RL; Santos, MM, 2011) |
| "Cilostazol treatment not only restored myelinated fiber density and size distribution but reversed some of the vascular abnormalities." | 1.30 | Effect of cilostazol on the neuropathies of streptozotocin-induced diabetic rats. ( Choi, YK; Kim, JW; Kim, SW; Kim, YS; Oh, SJ; Park, IK; Suh, KS; Woo, JT; Yang, IM, 1999) |
| "Cilostazol treatment (30 mg/kg/day p." | 1.29 | Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetes. ( Furuta, M; Kishi, Y; Mukoyama, M; Naka, K; Nanjo, K; Sanke, T; Sasaki, H, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asal, NJ | 1 |
| Wojciak, KA | 1 |
| Papanas, N | 1 |
| Maltezos, E | 1 |
| Rosales, RL | 1 |
| Santos, MM | 1 |
| Mercado-Asis, LB | 1 |
| Kihara, M | 1 |
| Schmelzer, JD | 1 |
| Low, PA | 1 |
| Naka, K | 1 |
| Sasaki, H | 1 |
| Kishi, Y | 1 |
| Furuta, M | 1 |
| Sanke, T | 1 |
| Nanjo, K | 1 |
| Mukoyama, M | 1 |
| Hotta, N | 1 |
| Koh, N | 1 |
| Sakakibara, F | 1 |
| Nakamura, J | 1 |
| Hamada, Y | 1 |
| Hara, T | 1 |
| Mori, K | 1 |
| Naruse, K | 1 |
| Fukasawa, H | 1 |
| Kakuta, H | 1 |
| Sakamoto, N | 1 |
| Yamamoto, Y | 1 |
| Yasuda, Y | 1 |
| Kimura, Y | 1 |
| Komiya, Y | 1 |
| Omoto, S | 1 |
| Nomura, S | 1 |
| Shouzu, A | 1 |
| Hayakawa, T | 1 |
| Shimizu, H | 1 |
| Miyake, Y | 1 |
| Yonemoto, T | 1 |
| Nishikawa, M | 1 |
| Fukuhara, S | 1 |
| Inada, M | 1 |
| Suh, KS | 1 |
| Oh, SJ | 1 |
| Woo, JT | 1 |
| Kim, SW | 1 |
| Yang, IM | 1 |
| Kim, JW | 1 |
| Kim, YS | 1 |
| Choi, YK | 1 |
| Park, IK | 1 |
| Okuda, Y | 1 |
| Mizutani, M | 1 |
| Ikegami, T | 1 |
| Ueno, E | 1 |
| Yamashita, K | 1 |
2 reviews available for cilostazol and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Effect of cilostazol in treating diabetes-associated microvascular complications.
Topics: Cilostazol; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Humans; Tetrazoles | 2017 |
Cilostazol in diabetic neuropathy: premature farewell or new beginning?
Topics: Cilostazol; Diabetic Neuropathies; Humans; Phosphodiesterase 3 Inhibitors; Tetrazoles; Treatment Out | 2011 |
1 trial available for cilostazol and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Cilostazol: a pilot study on safety and clinical efficacy in neuropathies of diabetes mellitus type 2 (ASCEND).
Topics: Adolescent; Adult; Aged; Cilostazol; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Dose-Response | 2011 |
7 other studies available for cilostazol and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Effect of cilostazol on experimental diabetic neuropathy in the rat.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Cilostazol; Diabetes Mellitus, Experimental; Di | 1995 |
Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetes.
Topics: Animals; Blood Glucose; Body Weight; Cilostazol; Cyclic AMP; Diabetes Mellitus, Experimental; Diabet | 1995 |
Nerve function and blood flow in Otsuka Long-Evans Tokushima Fatty rats with sucrose feeding: effect of an anticoagulant.
Topics: 2,3-Diphosphoglycerate; Alcohols; Animals; Anticoagulants; Blood Glucose; Body Weight; Carbohydrate | 1996 |
Effects of cilostazol, an antiplatelet agent, on axonal regeneration following nerve injury in diabetic rats.
Topics: Animals; Axons; Blood Glucose; Body Weight; Cilostazol; Diabetes Mellitus, Experimental; Diabetic Ne | 1998 |
Significance of platelet-derived microparticles and activated platelets in diabetic nephropathy.
Topics: Antigens, CD; Blood Coagulation; Blood Platelets; Case-Control Studies; Cilostazol; Diabetic Nephrop | 1999 |
Effect of cilostazol on the neuropathies of streptozotocin-induced diabetic rats.
Topics: Animals; Cilostazol; Cyclic AMP; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Neura | 1999 |
Hemodynamic effects of cilostazol on peripheral artery in patients with diabetic neuropathy.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Arteries; Blood Glucose; Cilostazol; Diabetic Neuropathie | 1992 |